Skip to Main Content

Paper Details

Longitudinal SARS-CoV-2 mRNA Vaccine-Induced Humoral Immune Responses in Patients with Cancer.
Cancer Res
30
2021
B, BNT162b2, COVID-19 illness, IgG-(S-RBD, Patients, SARS-CoV, SARS-CoV-2 mRNA, Solid tumor, anti-nucleocapsid immunoglobulin, anti-spike, cancer, hematologic malignancies, mRNA, mRNA-1273, patient, patients, solid tumors, tumor
Author NameAffiliation
Wendy CozenUniversity of California Irvine
Gil Y MelmedF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Jonathan BraunF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Jonathan BraunF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Dermot P B McGovernF. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Jennifer E Van EykSmidt Heart Institute, Cedars-Sinai Medical Center
Jennifer E Van EykAdvanced Clinical Biosystems Research Institute, Cedars-Sinai Medical Center
Jennifer E Van EykSmidt Heart Institute, Cedars-Sinai Medical Center
Jennifer E Van EykAdvanced Clinical Biosystems Research Institute, Cedars-Sinai Medical Center
Susan ChengSmidt Heart Institute, Cedars-Sinai Medical Center
  • 1 - 11

Datasets

Release 1.2